SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
KARACHI: While final lab tests for confirmation of an active TB infection in two Safari Park elephants are yet to be ...
Discover powerful fruits and vegetables that may help Black women navigate breast cancer treatment more comfortably while ...
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
Cellular therapy, according to the Dana-Farber Cancer Institute, is designed to improve the immune system’s ability to fight ...
Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a ...
Zacks Investment Research on MSN4d
GILD Data on Once-Yearly Lenacapavir for HIV Prevention PositiveGilead Sciences, Inc. GILD announced positive data from its ongoing phase I study evaluating pipeline candidate, lenacapavir.
The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...
Chronic diseases, such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases, are major global public health challenges, with their ...
Bachelorette Katie Thurston says she’s changed her mind about wanting to have kids, and is taking steps to make it happen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback